Philip Morris' Zyn Pouch Volumes Jump 36% Fueling 108% Return
Philip Morris delivered a 108% total return since January 2024 outperforming the S&P, driven by a 36% YoY increase in Zyn nicotine pouch volumes. Americas segment saw a one-off $100 million promotional boost in Q3.
1. Berman McAleer LLC Launches $481,000 Stake in Philip Morris International
In the third quarter, Berman McAleer LLC initiated a new position in Philip Morris International by acquiring 2,965 shares at a total cost of approximately $481,000, according to the firm’s latest SEC Form 13F filing. This marks the first reported investment by Berman McAleer in the company’s shares and represents a targeted entry into the tobacco and smoke-free products leader’s equity ahead of expected full-year results.
2. National Pension Service Expands Holdings by 2.7%
The National Pension Service increased its position in Philip Morris International by 2.7% during the same period, adding 98,450 shares to bring its total stake to 3,810,514 shares valued at roughly $618 million. The additional purchase underscores the pension fund’s confidence in the company’s long-term cash flows and dividend sustainability, with the holding representing approximately 0.24% of the company’s outstanding common stock.
3. Broader Institutional Activity Highlights Continued Confidence
Other major investors also adjusted their exposures to Philip Morris International in the second and third quarters. WCM Investment Management boosted its holding by over 24,900% to 11.28 million shares, valuing its stake at more than $2.04 billion, while Vanguard Group added 2.2 million shares (a 1.6% increase) to reach 142.86 million shares worth over $26.0 billion. Meanwhile, DZ BANK AG and Prudential Financial lifted their positions by 69.0% and 88.9%, respectively, reflecting an influx of institutional capital that now accounts for 78.6% of the company’s total shares outstanding.
4. Analyst Ratings Mixed Despite Moderate Buy Consensus
Following recent updates, the consensus among 13 Wall Street analysts remains “Moderate Buy,” with an average price target of $184.56. However, two firms have shifted to hold ratings, including one reducing its target from $220 to $180, while another trimmed its recommendation from buy to hold. Conversely, leading brokerages such as Goldman Sachs and Weiss Ratings reaffirmed buy assessments, citing resilient global cigarette volumes and upside potential in smoke-free product rollouts. Investors will be watching the company’s next quarterly report and dividend guidance closely, given the current annualized payout of $5.88 per share representing a 3.3% yield and a payout ratio above 100%.